NL, N., MS, M., JM, S. O., TS, S., LS, C., D, C., . . . JS, A. (2022). The effect of area-level disadvantage and race on smoking abstinence in a clinical trial. Experimental and clinical psychopharmacology, 30(3), 279. https://doi.org/10.1037/pha0000493
Chicago Style (17th ed.) CitationNL, Nollen, Mayo MS, Saint Onge JM, Scheuermann TS, Cox LS, Chae D, Leavens E, and Ahluwalia JS. "The Effect of Area-level Disadvantage and Race on Smoking Abstinence in a Clinical Trial." Experimental and Clinical Psychopharmacology 30, no. 3 (2022): 279. https://doi.org/10.1037/pha0000493.
MLA (9th ed.) CitationNL, Nollen, et al. "The Effect of Area-level Disadvantage and Race on Smoking Abstinence in a Clinical Trial." Experimental and Clinical Psychopharmacology, vol. 30, no. 3, 2022, p. 279, https://doi.org/10.1037/pha0000493.